Ausgabe 5/2022
Inhalt (6 Artikel)
Germline Predisposition to Myeloid Neoplasms (M. Patnaik, Section Editor)
ANKRD26-Related Thrombocytopenia and Predisposition to Myeloid Neoplasms
Mia J. Sullivan, Elizabeth L. Palmer, Juliana Perez Botero
Germline Predisposition to Myeloid Neoplasms (M Patnaik, Section Editor)
Germline and Somatic Defects in DDX41 and its Impact on Myeloid Neoplasms
Talha Badar, Timothy Chlon
Open Access
Chronic Myeloid Leukemias (V Oehler, Section Editor)
Management of Chronic Myeloid Leukemia in Children and Young Adults
Maegan Ford, Michael Mauro, Catherine Aftandilian, Kathleen M. Sakamoto, Nobuko Hijiya
Open Access
Myeloproliferative Neoplasms (P Bose, Section Editor)
Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
Barbara Mora, Francesco Passamonti
Myeloproliferative Neoplasms (P Bose, Section Editor)
Novel Therapies in Myelofibrosis: Beyond JAK Inhibitors
Julian A. Waksal, John Mascarenhas
Myeloproliferative Neoplasms (P Bose, Section Editor)
Advances in Risk Stratification and Treatment of Polycythemia Vera and Essential Thrombocythemia
Ivan Krecak, Marko Lucijanic, Srdan Verstovsek